Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$703M |
| 2 |
Tesla
TSLA
|
+$585M |
| 3 |
JPMorgan Chase
JPM
|
+$582M |
| 4 |
Amazon
AMZN
|
+$566M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$466M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$349M |
| 2 |
Home Depot
HD
|
+$334M |
| 3 |
T-Mobile US
TMUS
|
+$270M |
| 4 |
Cigna
CI
|
+$258M |
| 5 |
CDW
CDW
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.85% |
| 2 | Technology | 3.12% |
| 3 | Healthcare | 2.55% |
| 4 | Financials | 2.39% |
| 5 | Consumer Discretionary | 2.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
AUTL
5126
Autolus Therapeutics
AUTL
$487M
| $2.44M | ﹤0.01% |
1,142,605
-1,011,052
| -47% | -$3M |
2019 Q4
11 quarters
|
|
|
SLCA
5127
CALL
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $2.44M | ﹤0.01% |
223,100
+38,300
| +21% | +$487K |
2013 Q2
37 quarters
|
|
5128
CALL
Jack Henry & Associates
JKHY
$10.2B
| $2.44M | ﹤0.01% |
13,400
-2,300
| -15% | -$451K |
2017 Q2
21 quarters
|
|
|
AKRO
5129
CALL
DELISTED
Akero Therapeutics
AKRO
| $2.44M | ﹤0.01% |
+71,700
| New | +$1.1M |
2022 Q3
0 quarters
|
|
5130
Fidelity MSCI Materials Index ETF
FMAT
$578M
| $2.44M | ﹤0.01% |
+64,232
| New | +$2.71M |
2022 Q3
0 quarters
|
|
5131
Genworth Financial
GNW
$3.62B
| $2.44M | ﹤0.01% |
697,010
+269,100
| +63% | +$1.09M |
2020 Q4
7 quarters
|
|
5132
CALL
Vanguard S&P 500 Growth ETF
VOOG
$28.1B
| $2.44M | ﹤0.01% |
70,200
+22,200
| +46% | +$867K |
2021 Q2
5 quarters
|
|
|
DBRG
5133
CALL
DELISTED
DigitalBridge
DBRG
| $2.44M | ﹤0.01% |
195,000
+162,100
| +493% | +$3.12M |
2019 Q4
11 quarters
|
|
5134
PUT
Boston Properties
BXP
$9.48B
| $2.44M | ﹤0.01% |
32,500
-32,100
| -50% | -$2.73M |
2013 Q2
37 quarters
|
|
5135
Beazer Homes USA
BZH
$890M
| $2.44M | ﹤0.01% |
252,091
+99,894
| +66% | +$1.37M |
2022 Q1
2 quarters
|
|
5136
CALL
Cogent Communications
CCOI
$455M
| $2.44M | ﹤0.01% |
46,700
-5,300
| -10% | -$306K |
2013 Q2
37 quarters
|
|
5137
iShares US Small Cap Equity Factor ETF
SMLF
$4.15B
| $2.44M | ﹤0.01% |
+54,428
| New | +$2.69M |
2022 Q3
0 quarters
|
|
|
JOYY
5138
PUT
JOYY Inc
JOYY
$3.94B
| $2.44M | ﹤0.01% |
93,700
+4,600
| +5% | +$126K |
2016 Q2
25 quarters
|
|
|
UDMY
5139
DELISTED
Udemy
UDMY
| $2.44M | ﹤0.01% |
201,472
-41,762
| -17% | -$557K |
2021 Q4
3 quarters
|
|
|
VERV
5140
DELISTED
Verve Therapeutics
VERV
| $2.43M | ﹤0.01% |
70,830
-1,010,725
| -93% | -$32.3M |
2021 Q2
5 quarters
|
|
|
SRNE
5141
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $2.43M | ﹤0.01% |
1,549,054
+884,632
| +133% | +$2.01M |
2020 Q2
9 quarters
|
|
5142
CALL
Jefferies Financial Group
JEF
$10.6B
| $2.43M | ﹤0.01% |
86,190
+4,079
| +5% | +$123K |
2020 Q4
7 quarters
|
|
5143
CALL
Sensata Technologies
ST
$6.28B
| $2.43M | ﹤0.01% |
65,200
+54,700
| +521% | +$2.29M |
2020 Q2
9 quarters
|
|
5144
PUT
ProShares UltraPro Russell2000
URTY
$287M
| $2.43M | ﹤0.01% |
71,000
+12,500
| +21% | +$597K |
2021 Q1
6 quarters
|
|
5145
PUT
Boot Barn
BOOT
$3.72B
| $2.43M | ﹤0.01% |
41,500
-5,300
| -11% | -$355K |
2019 Q1
14 quarters
|
|
|
CRNX
5146
CALL
DELISTED
Crinetics Pharmaceuticals
CRNX
| $2.43M | ﹤0.01% |
123,500
-10,100
| -8% | -$206K |
2022 Q2
1 quarter
|
|
5147
PUT
Eastern Bankshares
EBC
$4.85B
| $2.43M | ﹤0.01% |
123,500
+26,100
| +27% | +$522K |
2020 Q4
7 quarters
|
|
5148
CALL
Acadia Pharmaceuticals
ACAD
$3.47B
| $2.42M | ﹤0.01% |
148,100
-309,100
| -68% | -$5.01M |
2013 Q2
37 quarters
|
|
|
PENG
5149
PUT
Penguin Solutions Inc
PENG
$3.11B
| $2.42M | ﹤0.01% |
152,700
-23,500
| -13% | -$428K |
2020 Q2
9 quarters
|
|
5150
iShares US Consumer Discretionary ETF
IYC
$1.18B
| $2.42M | ﹤0.01% |
41,607
+10,325
| +33% | +$658K |
2022 Q1
2 quarters
|
|
Similar funds
Citadel Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Citadel Advisors held 14,356 positions worth $439B, up 13% from $390B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Citadel Advisors's Q3 2022 filing shows 1,622 new, 5,458 increased, 5,221 reduced and 1,857 closed positions. Its largest new stake was SentinelOne: 4,426,634 shares worth $113M. The largest sale was Meta Platforms (Facebook), an estimated $349M.
By sector, the portfolio is most concentrated in Miscellaneous at 84% of assets, down from 84% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2022 buy was SentinelOne: 4,426,634 shares worth $113M.
- Citadel Advisors added most to Apple in Q3 2022, an estimated $703M increase.
- Citadel Advisors's biggest Q3 2022 reduction was Meta Platforms (Facebook), cutting an estimated $349M.
- Citadel Advisors fully exited Regions Financial in Q3 2022, selling an estimated $207M.
- Citadel Advisors's ten largest holdings make up 34% of its $439B portfolio in Q3 2022.
- Citadel Advisors opened 1,622 new positions and closed 1,857 in Q3 2022.
- Citadel Advisors's portfolio value rose 13% quarter-over-quarter to $439B.
Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.